Rainbow Children's Medicare Limited (RAINBOW) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹1,278.5 (+0.64% day change)
Key ratios
- P/E ratio
- 46.64
- P/B ratio
- 7.17
- ROE (%)
- 16.89
- ROCE (%)
- 15.19
- Debt/Equity
- 0.54
- Dividend yield (%)
- 0.26
- Market cap (₹ Cr)
- 12,985.29
Forensic checks
Piotroski F-Score: 4/9 · Altman Z-Score: 8.25 · Beneish M-Score: -1.55
InvestSights quality score
65.7/100 — Above Average (descriptive data-driven composite; not a recommendation)
Management guidance track record
- Occupancy: guided 55%, delivered 51.9% (FY25) — missed guidance
- Blended ARPP growth: guided 3–3.5%, delivered 4.5% (Q1 FY26) — exceeded guidance
Latest earnings call (Q2 FY27)
AI summary: The central signal is that Rainbow believes its mature and emerging hospital base can absorb the losses from a rapid commissioning cycle without materially disrupting consolidated profitability. Q2 revenue reached ₹548 crores with 23.2% growth, while EBITDA was ₹170 crores at a 31% margin, despite a weak monsoon and lower seasonal disease incidence. At the same time, newly…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.